Meeting
2023 ASCO Annual Meeting
Comparison of immune microenvironment between primary and metastatic breast tumors.
Authors
Heidi Chwan Ko
Labcorp Oncology, Durham, NC
Heidi Chwan Ko , Sarabjot Pabla , Mary K Nesline , Shipra Gandhi , Kyle C Strickland , Rebecca A. Previs , Zachary D Wallen , Shengle Zhang , Jeffrey M. Conroy , Mark Sausen , Jennifer B Jackson , Kamal S. Saini , Scott Wise , Taylor J. Jensen , Venkataprasanth P. Reddy , Eric A Severson , Shakti Ramkissoon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1030)
DOI
10.1200/JCO.2023.41.16_suppl.1030
Abstract #
1030
Poster Bd #
251
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
A phase II trial to assess the impact of β2 adrenergic blockade in immune checkpoint inhibitor (ICI)– refractory metastatic triple negative breast cancer (mTNBC).
First Author: Shipra Gandhi
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2023 ASCO Annual Meeting
Effect of a novel expansion process on tumor-infiltrating lymphocyte (TIL) polyfunctionality, cytotoxicity, and expansion, while preserving cells in a less differentiated and more stem-like phenotype.
First Author: Andrew Yuhas